Article info

Research paper
Amyloid-related imaging abnormalities-haemosiderin (ARIA-H) in patients with Alzheimer's disease treated with bapineuzumab: a historical, prospective secondary analysis

Authors

  1. Correspondence to Dr H Michael Arrighi, Janssen Pharmaceuticals Research & Development, 40 King Street, Mill Valley, South San Francisco, CA 94941, USA; marrighi{at}its.jnj.com
View Full Text

Citation

Arrighi HM, Barakos J, Barkhof F, et al
Amyloid-related imaging abnormalities-haemosiderin (ARIA-H) in patients with Alzheimer's disease treated with bapineuzumab: a historical, prospective secondary analysis

Publication history

  • Received September 28, 2014
  • Revised January 7, 2015
  • Accepted January 19, 2015
  • First published February 10, 2015.
Online issue publication 
December 17, 2015

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.